Caitong International Asset Management’s AC Immune ACIU Stock Holding History

Caitong International Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8	Buy	+3	New	+$9	﹤0.01%	2176

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Caitong International Asset Management's ACIU Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in AC Immune (ACIU) in Q1 2026: 3 shares worth $8. The stake represents ﹤0.01% of the portfolio and ranks #2176 among its holdings.

46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

Caitong International Asset Management held 3 shares of AC Immune worth $8 as of Q1 2026.
AC Immune was a new Caitong International Asset Management position in Q1 2026.
AC Immune made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #2176 holding.
46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.